相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A 33-year follow-up after valvular surgery for carcinoid heart disease
Johannes Bergsten et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2022)
Clinical Features and Prognosis of Patients with Carcinoid Syndrome and Carcinoid Heart Disease - a Retrospective Multicentric Study of 276 Patients
R. Fijalkowski et al.
NEUROENDOCRINOLOGY (2022)
Biomarkers in Small Intestine NETs and Carcinoid Heart Disease: A Comprehensive Review
Markos Kalligeros et al.
BIOLOGY-BASEL (2021)
Update in carcinoid heart disease-the heart of the matter
Kira Oleinikov et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2021)
Progression of Carcinoid Heart Disease in the Modern Management Era
Emilie Baron et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE for Symptomatic Control of Refractory Carcinoid Syndrome
Wouter T. Zandee et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Comparison of Serum and Urinary 5-Hydroxyindoleacetic Acid as Biomarker for Neuroendocrine Neoplasms
Anna Becker et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2021)
Serotonin: a platelet hormone modulating cardiovascular disease
Marina Rieder et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)
Peptide Receptor Radionuclide Therapy With Lu-177-DOTATATE for Symptomatic Control of Refractory Carcinoid Syndrome
Wouter T. Zandee et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
The 2019 WHO classification of tumours of the digestive system
Iris D. Nagtegaal et al.
HISTOPATHOLOGY (2020)
Carcinoid Heart Disease: Prognostic Value of 5-Hydroxyindoleacetic Acid Levels and Impact on Survival: A Systematic Literature Review
Amy Buchanan-Hughes et al.
NEUROENDOCRINOLOGY (2020)
Cardiac Imaging in Carcinoid Heart Disease
Tomasz Baron et al.
JACC-CARDIOVASCULAR IMAGING (2020)
Incidence Trends of Gastroenteropancreatic Neuroendocrine Tumors in the United States
Mi Ri Lee et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Management of carcinoid syndrome: a systematic review and meta-analysis
Johannes Hofland et al.
ENDOCRINE-RELATED CANCER (2019)
Mesenteric Fibrosis in Midgut Neuroendocrine Tumors: Functionality and Radiological Features
Victor Rodriguez Laval et al.
NEUROENDOCRINOLOGY (2018)
Carcinoid-syndrome: recent advances, current status and controversies
Tetsuhide Ito et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2018)
Carcinoid Heart Disease A Review
Aimee R. Hayes et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2018)
Diagnosing and Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors An Expert Statement
Joseph Davar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Serotonin and catecholamines in the development and progression of heart valve diseases
Elliott Goldberg et al.
CARDIOVASCULAR RESEARCH (2017)
ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum
B. Niederle et al.
NEUROENDOCRINOLOGY (2016)
Serial surveillance of carcinoid heart disease: factors associated with echocardiographic progression and mortality
R. Dobson et al.
BRITISH JOURNAL OF CANCER (2014)
Determination of the Optimal Echocardiographic Scoring System to Quantify Carcinoid Heart Disease
Rebecca Dobson et al.
NEUROENDOCRINOLOGY (2014)
Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
Martyn E. Caplin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Serotonin contracts the rat mesenteric artery by inhibiting 4-aminopyridine-sensitive Kv channels via the 5-HT2A receptor and Src tyrosine kinase
Dong Jun Sung et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2013)
Carcinoid Heart Disease
Chandrasekar Palaniswamy et al.
CARDIOLOGY IN REVIEW (2012)
Risk Factors for the Development and Progression of Carcinoid Heart Disease
Sanjeev Bhattacharyya et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Characteristics of the actions by which 5-HT affects electrical and mechanical activities in rabbit jugular vein
Takeo Itoh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Echocardiographic Follow-Up of Treated Patients With Carcinoid Syndrome
Nicolas Mansencal et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Anja Rinke et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study
Naomi M. Hamburg et al.
CIRCULATION (2008)
5-hydroxytryptamine and cardiovascular regulation
Andrew G. Ramage et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Intraoperative managnment of patients with carcinoid heart disease having valvular surgery: A review of one hundred consecutive cases
Toby N. Weingarten et al.
ANESTHESIA AND ANALGESIA (2007)
Multiaxial mechanical characteristics of carotid plaque - Analysis by multiarray echotracking system
Anna Paini et al.
STROKE (2007)
Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice
A Mekontso-Dessap et al.
CIRCULATION (2006)
5-Hydroxytryptamine receptors in the human cardiovascular system
Alberto J. Kaumann et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Long-term serotonin administration induces heart valve disease in rats
BI Gustafsson et al.
CIRCULATION (2005)
Essential biochemistry and physiology of (NT-pro)BNP
C Hall
EUROPEAN JOURNAL OF HEART FAILURE (2004)
Factors associated with progression of carcinoid heart disease
JE Moller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Prediction of prognosis by echocardiography in patients with midgut carcinoid syndrome
G Westberg et al.
BRITISH JOURNAL OF SURGERY (2001)